1,397 results on '"FERRARI, CARLO"'
Search Results
202. Systemic and Intrahepatic Interferon-Gamma-Inducible Protein 10 Kda Predicts the First-Phase Decline in Hepatitis C Virus Rna and Overall Viral Response to Therapy in Chronic Hepatitis C
203. Cooperative behaviors in multi-robot systems through implicit communication
204. International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
205. Modelling a Protein Structure Comparison Application on the Grid Using PROTEUS
206. Identifying Similar Surface Patches on Proteins Using a Spin-Image Surface Representation
207. Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C
208. Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment.
209. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences
210. Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C
211. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection
212. Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at day 0, day 22, day 29, and week 6
213. Hepatitis B virus immunopathology
214. A Dynamic Model for Mapping XML Elements in a Object-Oriented Fashion
215. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
216. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses
217. The influence of T cell cross-reactivity on HCV-peptide specific human T cell response
218. Bridging Deliberation and Reactivity in Cooperative Multi-Robot Systems through Map Focus
219. PaSo-Team 2000
220. Interferon (IFN) - (gamma) - inducible protein - 10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-(alpha)2a and ribavirin for chronic hepatitis C virus infection
221. Gravesʼ Disease in Interferon-α-Treated and Untreated Patients with Chronic Hepatitis C Virus Infection
222. PaSo-Team’99
223. Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma
224. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
225. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
226. The cellular immune response to nucleocapsid antigens in hepatitis B virus infection
227. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
228. Kinetics of the immune response during HBV and HCV infection
229. Immunopathogenesis of hepatitis B
230. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
231. The Role of Virus-specific CD8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection
232. Observatio paganorum: pratiche e comportamenti religiosi nella Gallia tardoantica (IV-VI secolo d.C.)
233. In silico prediction of blood cholesterol levels from genotype data
234. Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis
235. Impact of COVID-19 Pandemic on Cirrhotics with Hepatocellular Carcinoma During Follow-Up: Direct Consequences or Collateral Damages?
236. Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
237. Early Red Flags Associated with Delayed Discharge in Patients Undergoing Gastrectomy: Analysis of Perioperative Variables and ERAS Protocol Items
238. The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy
239. Thoracoscopic Resection of Congenital Lung Malformation: Looking for the Right Preoperative Assessment
240. Assessment of patient clinical descriptions and pathogenic variants from gene panel sequences in the CAGI‐5 intellectual disability challenge
241. Update of the statements on biology and clinical impact of occult hepatitis B virus infection
242. A global scientific strategy to cure hepatitis B
243. HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
244. PS-080-Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold
245. Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE‐I Part II)
246. Immunopathogenesis of hepatitis C virus infection
247. Value of ethanol injection in the treatment of the autonomous thyroid nodule
248. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]
249. Lamivudine Treatment Can Restore T Cell Responsiveness in Chronic Hepatitis B
250. Map focus: A way to reconcile reactivity and deliberation in multirobot systems
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.